News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Isogenica Limited to Exhibit at 2011 Biotechnology Industry Organization (BIO) International Convention, Booth 1405, Jun 27 - 30, 2011


6/28/2011 10:24:36 AM

Isogenica specialises in providing protein engineering services to pharmaceutical and biotechnology companies. Isogenica’s core drug discovery platform, “CIS display”, offers rapid discovery, identification & design of new peptide, polypeptide and antibody lead compounds. CIS display can quickly construct polypeptide libraries of unprecedented size (>10^13) and complexity in vitro, without the need for cloning. CIS display has provided hits and information against a wide range of targets and has advantages over alternative technologies. The technology is adaptable for the display of different proteins and licences are available for scFv & other polypeptide scaffolds. The technology is available for non-exclusive licensing in defined fields of research, or available under fee for service.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES